These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 31466489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The use of streptokinase for restoration of patency to hemodialysis central venous catheters: a low-cost, safe and effective option.
    Bashardoust B, Habibzadeh S, Sharghi A, Eskandari R, Maleki N.
    J Vasc Access; 2017 Sep 11; 18(5):e70. PubMed ID: 28777422
    [No Abstract] [Full Text] [Related]

  • 7. Managing dysfunctional central venous access devices: a practical approach to urokinase thrombolysis.
    Kumwenda M, Dougherty L, Spooner H, Jackson V, Mitra S, Inston N.
    Br J Nurs; 2018 Jan 25; 27(2):S4-S10. PubMed ID: 29368572
    [Abstract] [Full Text] [Related]

  • 8. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
    Clase CM, Crowther MA, Ingram AJ, Cinà CS.
    J Thromb Thrombolysis; 2001 Apr 25; 11(2):127-36. PubMed ID: 11406727
    [Abstract] [Full Text] [Related]

  • 9. Is the removal of a central venous catheter always necessary in the context of catheter-related right atrial thrombosis?
    Rossi L, Libutti P, Casucci F, Lisi P, Teutonico A, Basile C, Lomonte C.
    J Vasc Access; 2019 Jan 25; 20(1):98-101. PubMed ID: 29749281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alteplase versus urokinase for occluded hemodialysis catheters.
    Zacharias JM, Weatherston CP, Spewak CR, Vercaigne LM.
    Ann Pharmacother; 2003 Jan 25; 37(1):27-33. PubMed ID: 12503929
    [Abstract] [Full Text] [Related]

  • 12. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
    Shavit L, Lifschitz M, Plaksin J, Grenader T, Slotki I.
    Clin Nephrol; 2010 Oct 25; 74(4):297-302. PubMed ID: 20875382
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
    Bonkain F, Stolear JC, Catalano C, Vandervelde D, Treille S, Couttenye MM, Dhondt A, Libertalis M, Allamani M, Madhoun P, Van Craenenbroeck AH, Vanommeslaeghe F, Van Hulle F, Durieux P, Van Limberghen I, Tielemans C, Wissing KM.
    PLoS One; 2021 Oct 25; 16(5):e0251793. PubMed ID: 34015014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
    Haire WD, Deitcher SR, Mullane KM, Jaff MR, Firszt CM, Schulz GA, Schuerr DM, Schwartz LB, Mouginis TL, Barton RP.
    Thromb Haemost; 2004 Sep 25; 92(3):575-82. PubMed ID: 15351854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.